Bob Charles on Pyramid One Radio Network has been saying over and over and over, THIS IS KILLING PEOPLE
BUT ! As much as we say do not eat GMO food the World Population is Still doing it.
Look at People who died Recently, Young People Right !
KEEP UP FEEDING YOUR KIDS AND YOURSELF GMO FOOD AND YOUR NEXT ! RIP
BUT WHAT DO YOU CARE YOU CAN'T READ !
View photosMonsanto logo is displayed on a screen where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S. on May 9, 2016. REUTERS/Brendan McDermid/File Photo
(Reuters) - U.S. seeds and agrochemicals company Monsanto Co <MON.N>, which is being bought by Germany's Bayer <AG BAYGn.DE> for $66 billion, swung to a quarterly profit, helped by higher demand from South America. Sales of soybean seeds and traits jumped 37 percent as more farmers in South America sowed the company's genetically modified soybean seed Intacta RR2 Pro.
Monsanto agreed in September to a sweetened $128-per-share offer from Bayer that, if approved by regulators, would create a company commanding more than a quarter of the world market for seeds and pesticides. Monsanto, known for its genetically engineered corn and Roundup herbicide, did not offer any update on regulatory approvals or potential divestitures related to the Bayer deal. Bayer and Monsanto have said they are confident that the deal will pass regulatory scrutiny. Bayer has said it is committed to divest up to $1.6 billion of its portfolio to win approval.
Net profit attributable to Monsanto was $29 million, or 7 cents per share, in the first quarter ended Nov. 30, compared with a loss of $253 million, or 56 cents per share, a year earlier.
Excluding items, the company earned 21 cents per share.
Net sales rose more than 19 percent to $2.65 billion.